期刊文献+

动物气溶胶吸入暴露装置的研制 被引量:3

Development of an animal exposure device to aerosol inhalation
下载PDF
导出
摘要 目的:根据吸入药物治疗、疫苗气溶胶免疫和吸入毒理等研究及评价的需要,研制一种可进行包括药物、疫苗、微生物气溶胶、PM2.5粒子及纳米粒子等气溶胶动物吸入暴露的新装置。方法:根据小鼠、大鼠和豚鼠等实验动物的大小、呼吸量、一次实验的动物数量以及气溶胶均匀性要求,设计动物气溶胶吸入暴露系统;依据实验室生物安全和防护的要求,设计暴露装置的负压隔离防护系统;并对该装置进行性能测试验证。结果:经实验测试,该装置具有动物吸入暴露、防护功能,其性能达到了相关标准的要求。结论:动物气溶胶吸入暴露装置可进行动物气溶胶吸入暴露实验,具有对实验环境和人员的防护功能,以及对实验过程的压力、温湿度和含氧量实时监测的功能,适用于毒理、病原微生物和疫苗等气溶胶暴露研究的实验室。 Objective To develop a new animal aerosol exposure device making inhalationtoxicology investigation for drug aerosol, vaccine aerosol, microbiology aerosol, PM2.5 particlesand nanoparticles according to the research and evaluation on the treatment of drug inhalation,vaccine aerosols and toxicology inhalation. Methods: According to the size, respiratoryvolume, quantity of the experiment animal (including mice, rats and guinea pigs etc) andaerosol homogeneity, the animal aerosol exposure system has been designed. According to therequirements of laboratory biosafety and protection, the negative pressure protection systemhas been designed. The performance of the device have been tested and validated. Results:The performance of the device is up to relative standards by comparing with the testing results.Conclusion: The device has been used for animal aerosol exposure experiment. The device protects experimentalenvironment and operators from experimental aerosol, and can monitor the pressure, temperature, relative humidity,oxygen concentration of the exposure system in real time. It also can be suitable for all kinds of animal aerosol exposurein laboratory.
出处 《中国医学装备》 2016年第9期1-5,共5页 China Medical Equipment
基金 国家科技重大专项(2012ZX10003005/09)"气溶胶暴露装置的研制及在结核病治疗中的应用"
关键词 气溶胶 实验动物 吸入暴露设备 设计原理 Aerosol Experiment animal Inhaled exposure apparatus Design and principle
  • 相关文献

参考文献14

  • 1Zhang L,Yu CP.Empirical equations fornasal deposition of inhaled particles in smalllaboratory animals and humans[J].Aerosol SciTech,1993,19(1):51-56.
  • 2Reed DS,Martinez MJ.Respiratory immunity isan important component of protection elicitedby subunit vaccination against pneumonicplague[J].Vaccine,2006,24(13):2283-2289.
  • 3Morris SR.Development of a recombinantvaccine against aerosolized plague[J].Vaccine,2007,25(15):3115-3117.
  • 4Wimer-Mackin S,Hinchcliffe M,Petrie CR,et al.An intranasal vaccine targeting both theBacillus anthracis toxin and bacterium providesprotection against aerosol spore challenge inrabbits[J].Vaccine,2006,24(18):3953-3963.
  • 5Vipond J,Simon OC,Hatch GJ,et al.Reformulationof selected DNA vaccine candidatesand their evaluation as protein vaccinesusing a guinea pig aerosol infection modelof tuberculosis[J].Tuberculosis,2006,86(3-4):218-224.
  • 6T i g e r t t W D , B e n e n s o n A S , G o c h e n o u rWS.Airborne Q fever[J].Bact rev,1961,25(9):285-293.
  • 7Yeh HC,Schum GM,Duggan MT.Anatomicmodels of the tracheobronchial and pulmonaryregions of the rat[J].Anat Rec,1979,195(3):483-492.
  • 8温占波,李娜,李劲松,杨文慧,王洁,胡凌飞,董晓凯,鹿建春.动物口鼻动态气溶胶暴露系统的建立与效果评价[J].解放军预防医学杂志,2012,30(6):402-405. 被引量:3
  • 9Ivins B,Fellows P,Pitt L,et al.Experimentalanthrax vaccines:efficacy of adjuvants combinedwith protective antigen against an aerosolBacillus anthracis spore challenge in guineapigs[J].Vaccine,1995,13(8):1779-17134.
  • 10.Oldham MJ,Phalen RF,Thomas Budiman.Comparison of predicted and experimentallymeasured aerosol deposition efficiency inBALB/C mice in a new Nose-Only exposuresystem[J].Aerosol Sci Tech,2009,43(10):970-977.

二级参考文献8

  • 1WIMER-MACKIN S,HINCHCLIFFE M,PETRIE C R, etal. An intranasal vaccine targeting both the bacillus an-thracis toxin and bacterium provides protection againstaerosol spore challenge in rabbits[ J]. Vaccine, 2006,24(18) :3953.
  • 2ANDERSEN A A. New sampler for the collection, sizing,and enumeration of viable particles[ J]. J Bacteriol,1958,76(5):471.
  • 3MORRIS S R. Development of a recombinant vaccine a-gainst aerosolized plague[J]. Vaccine,2007,25:3115.
  • 4CONLAN J W, SHEN H, KUOLEE R, et al. Aerosol butnot intradermal - immunization with the live vaccine strainof francisella tularensis protects mice against subsequentaerosol challenge with a highly virulent type A strain of thepathogen by an ctP T cell - and interferon gamma - de-pendent mechanism[J]. Vaccine, 2005 , 23( 19) :2477?.
  • 5EYLES J E, HARTLEY M G,LAWS TR, et al. Protec-tion afforded against aerosol challenge by systemic immuni-zation with inactivated francisella tularensis live vaccinestrain (LVS)[J]. Microbial Pathogenesis, 2008,44(2):164.
  • 6PALENDIRA U, SPRATT J M,BRITTON W J, et al.Expanding the antigenic repertoire of BCG improves pro-tective efficacy against aerosol Mycobacterium tuberculosisinfection[J). Vaccine, 2005,23( 14) :1680.
  • 7VIPOND J,SIMON O C, HATCH GJ’et al. Reformula-tion of selected DNA vaccine candidates and their evalua-tion as protein vaccines using a guinea pig aerosol infectionmodel of tuberculosis[ J]. Tuberculosis,2006,86 (3-4 ):218.
  • 8HARTINGS J M, ROY C J. The automated bioaerosol ex-posure system : preclinical platform development and a re-spiratory dosimetry application with nonhuman primates[J]. Journal of pharmacological and toxicological meth-ods, 2004,49(1):39.

共引文献2

同被引文献6

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部